Amryt Supports Global Rare Disease Day 2021 pharmiweb.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pharmiweb.com Daily Mail and Mail on Sunday newspapers.
A
Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient: 1. Obtains access to the information in a personal capacity; 2. Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services; 3. Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body; 4. Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Share:
Amryt and Medison Pharma Sign Multi-Regional Distribution Agreements in Canada and Israel
DUBLIN, Ireland, and Boston MA, February 4, 2021, Amryt (NASDAQ:AMYT, AIM: AMYT)), a global, commercial-stage biopharmaceutical company dedicated to acquiring, developing and commercializing novel therapeutics to treat patients suffering from serious and life-threatening rare diseases, today announces the signing of multi-regional distribution agreements with Medison Pharma ( Medison ) to distribute Juxtapid® (lomitapide) in Canada and Lojuxta® (lomitapide) and Myalept® (metreleptin) in Israel.
Dr Joe Wiley, CEO of Amryt Pharma, commented today:
Today s announcement is another positive development as we continue to grow our commercial assets in existing and new territories and we further progress towards our goal of becoming a global leader in rare and orphan diseases. We are excited to be working with Medison to leverage their expertise and presence in these territories.
Recommended acquisition of Cpl Resources plc by Outsourcing Talent Ireland Limited, a wholly-owned subsidiary of OUTSOURCING Inc. Scheme is Effective Cpl Resources plc ( Cpl ) and OUTSOURCING Inc. ( OUTSOURCING ) are pleased to announce that the Scheme became effective today, 21 January 2021. Despatch of cheques and crediting of CREST accounts for Consideration due under the Scheme is expected to occur on 3 February 2021 and in any event by no later than 4 February 2021, in accordance with the terms of the Scheme. Trading of Cpl Shares on Euronext Growth and AIM has been suspended from 7:30 a.m. today and cancellation of Cpl Shares to trading on Euronext Growth and AIM will take effect from 7:00 a.m. on 22 January 2021.
Recommended acquisition of Cpl Resources plc by Outsourcing Talent Ireland Limited, a wholly-owned subsidiary of OUTSOURCING Inc. Court Approval The board of directors of Cpl Resources plc ( Cpl ) announces that the High Court has today approved the Scheme. The Scheme shall become effective on delivery to the Registrar of Companies of the Court Order and registration of the Court Order by the Registrar of Companies. This is expected to occur on 21 January 2021. Accordingly, the Scheme is expected to take effect on 21 January 2021. Trading of Cpl Shares on Euronext Growth and AIM will be suspended from 7:30 a.m. on 21 January 2021 and cancellation of Cpl Shares to trading on Euronext Growth and AIM will, subject to the Scheme becoming effective on